ADIPOQ and Obesity: In females, estrogen is associated with reduced visceral fat accumulation and increased adiponectin secretion, which may partly explain the stronger associations between obesity indices (e.g., BMI and CVAI) and T2DM risk observed in women in our cohort (49).